Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cimpress (CMPR) Asset Writedowns and Impairment (2016 - 2024)

Cimpress (CMPR) has 9 years of Asset Writedowns and Impairment data on record, last reported at -$1.4 million in Q2 2024.

  • For Q2 2024, Asset Writedowns and Impairment fell 119.0% year-over-year to -$1.4 million; the TTM value through Mar 2024 reached $9.0 million, up 273.78%, while the annual FY2023 figure was $5.6 million, N/A changed from the prior year.
  • Asset Writedowns and Impairment reached -$1.4 million in Q2 2024 per CMPR's latest filing, down from $328000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $20.6 million in Q1 2021 and bottomed at -$19.9 million in Q2 2021.
  • Average Asset Writedowns and Impairment over 5 years is $669400.0, with a median of $549000.0 recorded in 2023.
  • Peak YoY movement for Asset Writedowns and Impairment: plummeted 630.05% in 2021, then skyrocketed 343.08% in 2022.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $3.8 million in 2020, then decreased by 27.67% to $2.7 million in 2021, then tumbled by 320.68% to -$6.0 million in 2022, then skyrocketed by 109.84% to $589000.0 in 2023, then plummeted by 344.82% to -$1.4 million in 2024.
  • Per Business Quant database, its latest 3 readings for Asset Writedowns and Impairment were -$1.4 million in Q2 2024, $328000.0 in Q1 2024, and $589000.0 in Q4 2023.